Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis

PurposeTo identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features.MethodsThe protocol of this study was registered on PROSPERO (CRD42021234475). Relevant studies were identified by searching the PubMed, Cochrane librar...

Full description

Bibliographic Details
Main Authors: Pengju Guo, Yongxing Wang, Yili Han, Dechao Wei, Jiahui Zhao, Mingchuan Li, Yongguang Jiang, Yong Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.678459/full
id doaj-aaa271d5dfb5480292af963f9f5ded72
record_format Article
spelling doaj-aaa271d5dfb5480292af963f9f5ded722021-06-03T05:18:52ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.678459678459Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative SynthesisPengju GuoYongxing WangYili HanDechao WeiJiahui ZhaoMingchuan LiYongguang JiangYong LuoPurposeTo identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features.MethodsThe protocol of this study was registered on PROSPERO (CRD42021234475). Relevant studies were identified by searching the PubMed, Cochrane library, Embase, and Web of Science databases. Cancer-specific survival (CSS) was selected as the endpoint. Pooled hazard ratio (HR) and 95% confidence interval (CI) extracted from multivariate Cox models were evaluated to identify the hazard association.ResultsA total of 22 studies, which enrolled 12384 patients were included for quantitative synthesis. Sinus fat invasion (SFI) + perinephric fat invasion (PFI) was associated with inferior CSS compared to SFI only (p = 0.02). Comparable CSS was observed between SFI and PFI (p = 0.57). SFI ± PFI showed inferior CSS compared to PFI only (p = 0.0002). The presence of pelvicalyceal system invasion significantly increased the risk of cancer-specific mortality (p = 0.0005). Renal vein invasion (RVI) indicated poor oncological outcomes in terms of CSS (p = 0.002). The concomitant RVI and fat invasion (FI) significantly increased the risk of deterioration of CSS compared to RVI or FI (p < 0.0001). Multiple invasion patterns translated into a significantly decreased CSS (p < 0.0001). Aggressive tumor behavior, including lymph node involvement (p = 0.006), distant metastases (p < 0.00001), sarcomatoid differentiation (p < 0.0001), necrosis (p < 0.0001), Fuhrman grade III or IV (p < 0.0001), positive margin (p < 0.0001), and tumor size >7cm (p < 0.0001) were the predictors of inferior CSS. The lymphovascular invasion (p = 0.67) was indolent in terms of CSS.ConclusionThis study confirmed the heterogenicity of pT3a renal tumors. Multiple invasion patterns could translate into a significantly decreased CSS, and SFI should not be merged in the SFI + PFI group. The presence of PSI or RVI could significantly increase the risk of cancer-specific mortality. Lymph node involvement, distant metastases, sarcomatoid differentiation, necrosis, high Fuhrman grade, positive margin, and size >7cm were the predictors of inferior CSS. A precise-risk grade of CSS for different invasion patterns including comprehensive combinations may be useful for the further refinements of the TNM system.Systematic Review RegistrationThe current study was registered on PROSPERO, and the registration numbers is CRD42021234475.https://www.frontiersin.org/articles/10.3389/fonc.2021.678459/fullrenal tumorpT3anephrectomycancer-specific survivalsystematic review
collection DOAJ
language English
format Article
sources DOAJ
author Pengju Guo
Yongxing Wang
Yili Han
Dechao Wei
Jiahui Zhao
Mingchuan Li
Yongguang Jiang
Yong Luo
spellingShingle Pengju Guo
Yongxing Wang
Yili Han
Dechao Wei
Jiahui Zhao
Mingchuan Li
Yongguang Jiang
Yong Luo
Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
Frontiers in Oncology
renal tumor
pT3a
nephrectomy
cancer-specific survival
systematic review
author_facet Pengju Guo
Yongxing Wang
Yili Han
Dechao Wei
Jiahui Zhao
Mingchuan Li
Yongguang Jiang
Yong Luo
author_sort Pengju Guo
title Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
title_short Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
title_full Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
title_fullStr Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
title_full_unstemmed Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis
title_sort oncological outcomes of patients with different pathological features of pt3a renal tumor: a systematic review and quantitative synthesis
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
description PurposeTo identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features.MethodsThe protocol of this study was registered on PROSPERO (CRD42021234475). Relevant studies were identified by searching the PubMed, Cochrane library, Embase, and Web of Science databases. Cancer-specific survival (CSS) was selected as the endpoint. Pooled hazard ratio (HR) and 95% confidence interval (CI) extracted from multivariate Cox models were evaluated to identify the hazard association.ResultsA total of 22 studies, which enrolled 12384 patients were included for quantitative synthesis. Sinus fat invasion (SFI) + perinephric fat invasion (PFI) was associated with inferior CSS compared to SFI only (p = 0.02). Comparable CSS was observed between SFI and PFI (p = 0.57). SFI ± PFI showed inferior CSS compared to PFI only (p = 0.0002). The presence of pelvicalyceal system invasion significantly increased the risk of cancer-specific mortality (p = 0.0005). Renal vein invasion (RVI) indicated poor oncological outcomes in terms of CSS (p = 0.002). The concomitant RVI and fat invasion (FI) significantly increased the risk of deterioration of CSS compared to RVI or FI (p < 0.0001). Multiple invasion patterns translated into a significantly decreased CSS (p < 0.0001). Aggressive tumor behavior, including lymph node involvement (p = 0.006), distant metastases (p < 0.00001), sarcomatoid differentiation (p < 0.0001), necrosis (p < 0.0001), Fuhrman grade III or IV (p < 0.0001), positive margin (p < 0.0001), and tumor size >7cm (p < 0.0001) were the predictors of inferior CSS. The lymphovascular invasion (p = 0.67) was indolent in terms of CSS.ConclusionThis study confirmed the heterogenicity of pT3a renal tumors. Multiple invasion patterns could translate into a significantly decreased CSS, and SFI should not be merged in the SFI + PFI group. The presence of PSI or RVI could significantly increase the risk of cancer-specific mortality. Lymph node involvement, distant metastases, sarcomatoid differentiation, necrosis, high Fuhrman grade, positive margin, and size >7cm were the predictors of inferior CSS. A precise-risk grade of CSS for different invasion patterns including comprehensive combinations may be useful for the further refinements of the TNM system.Systematic Review RegistrationThe current study was registered on PROSPERO, and the registration numbers is CRD42021234475.
topic renal tumor
pT3a
nephrectomy
cancer-specific survival
systematic review
url https://www.frontiersin.org/articles/10.3389/fonc.2021.678459/full
work_keys_str_mv AT pengjuguo oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT yongxingwang oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT yilihan oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT dechaowei oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT jiahuizhao oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT mingchuanli oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT yongguangjiang oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
AT yongluo oncologicaloutcomesofpatientswithdifferentpathologicalfeaturesofpt3arenaltumorasystematicreviewandquantitativesynthesis
_version_ 1721399499166842880